Bernard Le Foll

ResearcherID Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 33

Top Topics

Magnetic Resonance

Randomized Controlled Trial

Alcohol Use Disorder

Top Venues

International journal of molecular sciences

Journal of dual diagnosis

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Anthony Ngoy, Victor M Tang, Kebin Xiao, Daniel M Blumberger, Tony P George, Joshua L Gowin, Bernard Le Foll, Matthew E Sloan
Neuromodulation for Cannabis Use: A Scoping Review. Brain sciences 14 (4) (2024)
Sonja Elsaid, Ruoyu Wang, Stefan Kloiber, Rebecca Haines-Saah, Ahmed N Hassan, Bernard Le Foll
Expectancies of the Effects of Cannabis Use in Individuals with Social Anxiety Disorder (SAD). Brain sciences 14 (3) (2024)
Sonja Elsaid, Ruoyu Wang, Stefan Kloiber, Rebecca Haines-Saah, Ahmed N Hassan, Bernard Le Foll
Expectancies of the Effects of Cannabis Use in Individuals with Social Anxiety Disorder (SAD). Brain sciences 14 (3) (2024)
Gabriel Bastien, Anita Abboud, Christina McAnulty, Laurent Elkrief, Omar Ledjiar, Maria Eugenia Sociás, Bernard Le Foll, Anees Bahji, Suzanne Brissette, Stéphanie Marsan, Didier Jutras-Aswad
Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription-Type Opioid Use Disorder: Results From a Pragmatic Randomized Controlled Trial. Journal of dual diagnosis 20 (3) (2024)
Gabriel Bastien, Anita Abboud, Christina McAnulty, Laurent Elkrief, Omar Ledjiar, Maria Eugenia Sociás, Bernard Le Foll, Anees Bahji, Suzanne Brissette, Stéphanie Marsan, Didier Jutras-Aswad
Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription-Type Opioid Use Disorder: Results From a Pragmatic Randomized Controlled Trial. Journal of dual diagnosis (2024)
Anthony Ngoy, Victor M Tang, Kebin Xiao, Daniel M Blumberger, Tony P George, Joshua L Gowin, Bernard Le Foll, Matthew E Sloan
Neuromodulation for Cannabis Use: A Scoping Review. Brain sciences 14 (4) (2024)
Sonja Elsaid, Ruoyu Wang, Stefan Kloiber, Bernard Le Foll, Ahmed N Hassan
Motivations for Cannabis Use in Individuals with Social Anxiety Disorder (SAD). Brain sciences 13 (12) (2023)
Sonja Elsaid, Peter Truong, Napapon Sailasuta, Bernard Le Foll
Evaluating Back-to-Back and Day-to-Day Reproducibility of Cortical GABA+ Measurements Using Proton Magnetic Resonance Spectroscopy ( 1 H MRS). International journal of molecular sciences 24 (9) (2023)
Leen Magarbeh, Ilona Gorbovskaya, Richard Wells, Reuven Jhirad, Bernard Le Foll, Daniel J Müller
Pharmacogenetics of Lethal Opioid Overdose: Review of Current Evidence and Preliminary Results from a Pilot Study. Journal of personalized medicine 13 (6) (2023)
Sonja Elsaid, Ruoyu Wang, Stefan Kloiber, Bernard Le Foll, Ahmed N Hassan
Motivations for Cannabis Use in Individuals with Social Anxiety Disorder (SAD). Brain sciences 13 (12) (2023)
Benedikt Fischer, Wayne Denis Hall, Thiago Marques Fidalgo, Eva Hoch, Bernard Le Foll, María Elena Medina Mora, Jens Reimer, Philip G Tibbo, Didier Jutras-Aswad
Recommendations for Reducing the Risk of Cannabis Use-Related Adverse Psychosis Outcomes: A Public Mental Health-Oriented Evidence Review. Journal of dual diagnosis (2023)
Intishar Kazi, Meghan J Chenoweth, Didier Jutras-Aswad, Keith Ahamad, M Eugenia Socias, Bernard Le Foll, Rachel Fynvola Tyndale
Pharmacogenetics of Biochemically Verified Abstinence in an Opioid Agonist Therapy Randomized Clinical Trial of Methadone and Buprenorphine/Naloxone. Clinical pharmacology and therapeutics (2023)
Sonja Elsaid, Peter Truong, Napapon Sailasuta, Bernard Le Foll
Evaluating Back-to-Back and Day-to-Day Reproducibility of Cortical GABA+ Measurements Using Proton Magnetic Resonance Spectroscopy ( 1 H MRS). International journal of molecular sciences 24 (9) (2023)
Leen Magarbeh, Ilona Gorbovskaya, Richard Wells, Reuven Jhirad, Bernard Le Foll, Daniel J Müller
Pharmacogenetics of Lethal Opioid Overdose: Review of Current Evidence and Preliminary Results from a Pilot Study. Journal of personalized medicine 13 (6) (2023)
Nadia Boachie, Erin Gaudette, Richard P Bazinet, Lin Lin, Rachel Fynvola Tyndale, Esmaeil Mansouri, Marilyn Ann Huestis, Junchao Tong, Bernard Le Foll, Stephen J Kish, Tony P George, Isabelle Boileau
Circulating Endocannabinoids and N-Acylethanolamines in Individuals with Cannabis Use Disorder-Preliminary Findings. Brain sciences 13 (10) (2023)
Sonja Elsaid, Dafna S Rubin-Kahana, Stefan Kloiber, Sidney H Kennedy, Sofia E Chavez, Bernard Le Foll
Neurochemical Alterations in Social Anxiety Disorder (SAD): A Systematic Review of Proton Magnetic Resonance Spectroscopic Studies. International journal of molecular sciences 23 (9) (2022)
Suzanne Nielsen, Louisa Picco, Bridin Murnion, Bryony L Winters, Justin Matheson, Myfanwy Graham, Gabrielle Campbell, Laila Parvaresh, Kok-Eng Khor, Brigid Betz-Stablein, Michael Farrell, Nicholas Lintzeris, Bernard Le Foll
Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 47 (7) (2022)
Justin Matheson, Yollanda J Zhang, Bruna Brands, Christine M Wickens, Arun K Tiwari, Clement C Zai, James L Kennedy, Bernard Le Foll
Association between ABCB1 rs2235048 Polymorphism and THC Pharmacokinetics and Subjective Effects following Smoked Cannabis in Young Adults. Brain sciences 12 (9) (2022)
Justin Matheson, Zoe Bourgault, Bernard Le Foll
Sex Differences in the Neuropsychiatric Effects and Pharmacokinetics of Cannabidiol: A Scoping Review. Biomolecules 12 (10) (2022)
Claire Shyu, Sofia E Chavez, Isabelle Boileau, Bernard Le Foll
Quantifying GABA in Addiction: A Review of Proton Magnetic Resonance Spectroscopy Studies. Brain sciences 12 (7) (2022)
Zoe Bourgault, Christine Ibrahim, Bernard Le Foll, Ahmed N Hassan
Comparing immediate- and delayed-onset posttraumatic stress disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III). Journal of traumatic stress 35 (6) (2022)
Chidera C Chukwueke, Christina N Nona, Matthew D McPhee, Esmaeil Mansouri, Dafna S Rubin-Kahana, Diana Martinez, Isabelle Boileau, Christian S Hendershot, Bernard Le Foll
Exploring regulation and function of dopamine D3 receptors in alcohol use disorder. A PET [11C]-(+)-PHNO study. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 46 (12) (2021)
Victor M Tang, Bernard Le Foll, Daniel M Blumberger, Daphne Voineskos
Repetitive Transcranial Magnetic Stimulation for Comorbid Major Depressive Disorder and Alcohol Use Disorder. Brain sciences 12 (1) (2021)
Claire Shyu, Sonja Elsaid, Peter Truong, Sofia Chavez, Bernard Le Foll
MR Spectroscopy of the Insula: Within- and between-Session Reproducibility of MEGA-PRESS Measurements of GABA+ and Other Metabolites. Brain sciences 11 (11) (2021)
Mashal Ahmed, Isabelle Boileau, Bernard Le Foll, Andre Fèrrer Carvalho, Stefan Kloiber
The endocannabinoid system in social anxiety disorder: from pathophysiology to novel therapeutics. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) (2021)
Thomas Murphy, Justin Matheson, Robert E Mann, Bruna Brands, Christine M Wickens, Arun K Tiwari, Clement C Zai, James Kennedy, Bernard Le Foll
Influence of Cannabinoid Receptor 1 Genetic Variants on the Subjective Effects of Smoked Cannabis. International journal of molecular sciences 22 (14) (2021)
Justin Matheson, Xin Ming Matthew Zhou, Zoe Bourgault, Bernard Le Foll
Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review. Pharmaceuticals (Basel, Switzerland) 14 (12) (2021)
Thomas Murphy, Bernard Le Foll
Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs. Biomolecules 10 (6) (2020)
Murat Yücel, Erin Oldenhof, Serge H Ahmed, David Belin, Billieux Joël, Henrietta Bowden-Jones, Adrian Carter, Samuel R Chamberlain, Luke Clark, Jason Connor, Mark R C Daglish, Geert Dom, Pinhas Dannon, Theodora Duka, Maria Jose Fernandez-Serrano, Matt Field, Ingmar Franken, Rita Z Goldstein, Raul Gonzalez, Anna E Goudriaan, Jon E Grant, Matthew J Gullo, Robert Hester, David Carson Hodgins, Bernard Le Foll, Rico S C Lee, Anne Lingford-Hughes, Valentina Lorenzetti, Scott J Moeller, Marcus R Munafo, Brian L Odlaug, Marc N Potenza, Rebecca Segrave, Zsuzsika Sjoerds, Nadia Solowij, Wim van den Brink, Ruth J van Holst, Valerie Voon, Reinout W Wiers, Leonardo F Fontenelle, Antonio Verdejo-Garcia
A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study. Addiction (Abingdon, England) 114 (6) (2018)
Laurie Zawertailo, Tara Mansoursadeghi-Gilan, Helena Zhang, Sarwar Hussain, Bernard Le Foll, Peter L Selby
Varenicline and Bupropion for Long-Term Smoking Cessation (the MATCH Study): Protocol for a Real-World, Pragmatic, Randomized Controlled Trial. JMIR research protocols 7 (10) (2018)
Jose M Trigo, Alexandra Soliman, Lena C Quilty, Benedikt Fischer, Jürgen Rehm, Peter Selby, Allan J Barnes, Marilyn A Huestis, Tony P George, David L Streiner, Gregory Staios, Bernard Le Foll
Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial. PloS one 13 (1) (2018)
Marie N S Gendy, Patricia Di Ciano, William J Kowalczyk, Sean P Barrett, Tony P George, Stephen Heishman, Bernard Le Foll
Testing the PPAR hypothesis of tobacco use disorder in humans: A randomized trial of the impact of gemfibrozil (a partial PPARα agonist) in smokers. PloS one 13 (9) (2018)
Bernard Le Foll, Thulasi Thiruchselvam, Shawna Xiaoyun Lu, Shakira Mohammed, Esmaeil Mansouri, Dina Lagzdins, Shinichiro Nakajima, Alan A Wilson, Ariel Graff-Guerrero, Patricia Di Ciano, Isabelle Boileau
Investigating the effects of norepinephrine α1 receptor blockade on dopamine levels: A pilot PET study with [11 C]-(+)-PHNO in controls. Synapse (New York, N.Y.) 71 (7) (2017)